Guest guest Posted September 17, 2004 Report Share Posted September 17, 2004 WASHINGTON (Reuters) - & added a new warning to the label for rheumatoid arthritis drug Remicade about blood disorders that sometimes were fatal, U.S. regulators announced on Tuesday. & , in a letter to doctors said the "causal relationship" between Remicade and the disorders "remains unclear." The reported problems included a dangerous reduction in the number of white blood cells that can leave patients vulnerable to infections. The company also added warning language about rare cases of blood vessel inflammation in the brain and spinal cord experienced by patients treated with Remicade. Here is the link to rest of this article, I found doing a search in Google. http://www.reuters.com/newsArticle.jhtml?type=healthNews & storyID=6059613 Becky Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.